Omega Healthcare Investors Q4 Earnings Call Highlights

Core Insights - Omega Healthcare Investors reported strong fourth-quarter results with adjusted funds from operations (AFFO) of $0.80 per share and funds available for distribution (FAD) of $0.76 per share, reflecting growth driven by new investments and reduced interest expenses [1][3][6] - The company achieved a revenue increase to $319 million in the fourth quarter, up from $279 million year-over-year, with net income rising to $172 million compared to $116 million in the prior-year quarter [2][4] Financial Performance - Fourth-quarter FAD increased by one cent from the previous quarter, supported by $485 million in new investments and approximately $1 million in lower net interest expenses [1] - Full-year AFFO and FAD growth exceeded 8% year-over-year, aided by $1.1 billion in capital deployment [3][6] - The dividend payout ratio decreased to 84% of AFFO and 88% of FAD [3][6] Portfolio and Investment Activity - Omega now owns or partners in 1,111 facilities and completed over $1.1 billion in transactions during 2025, including expansions and new stakes in various facilities [5][12] - The company is monitoring the Genesis Chapter 11 bankruptcy, with expectations for resolution in Q3 or Q4 of 2026 [5][9][10] - Recent investments include a $93 million purchase of 9.9% of Saber's operating company equity and a $109 million acquisition of skilled nursing facilities in Georgia [13][14] Balance Sheet and Leverage - Omega significantly strengthened its balance sheet by reducing funded debt by over $700 million, including a $600 million note payoff, resulting in a leverage ratio of 3.51x [6][7] - The company ended 2025 with $27 million in cash and over $1.7 billion in revolver capacity, alongside a new $2 billion at-the-market program [7][8] Guidance and Future Outlook - Full-year 2026 adjusted FFO guidance is set between $3.15 and $3.25 per share, factoring in completed investments and scheduled loan repayments [16] - Management indicated a conservative approach to RIDEA underwriting and is considering increasing the dividend, contingent on board decisions [18] Regulatory Environment - Recent legislative changes addressed a 4% Medicare cut, and minimum staffing standards were repealed, which Omega welcomed [17] - The company anticipates minimal impact from CMS's proposal for flat rates in 2027 due to low Medicare Advantage exposure [17]